||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 537 active entries
7150 rue Frederick-Banting, Suite 200
Saint-Laurent, H4S 2A1
Phone: (514) 282-9990
Fax: (514) 282-9990
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
BioAxone Therapeutic, a neuroscience company, is developing an experimental therapy for the treatment of neurological disorders. Our lead drug, Cethrin, is in clinical trial for spinal cord injury throughout Canada and the United States. The modified C3 exoenzyme provides neuroprotection and neuroregeneration by inhibiting Rho GTPase signaling.
- - General
Last update of this entry: October 12, 2006